AI Summary
✦ ClarthaValuation Metrics
Trading 46.7% above historical median. Valuation is rising — currently in the strongly overvalued zone (z-score: +1.3). Confidence: 74%.
Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.
5Y Average
—
Current
2915.25
Overvalued
2750.50
Undervalued
1694.50
5Y Average
2.84
Current
4.23
Overvalued
3.27
Undervalued
2.41
5Y Average
3.66
Current
4.13
Overvalued
4.21
Undervalued
3.11
Peers & Comparison
Sector: Health Care · Theme: Hospitals & Diagnostic Centres
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
GUJARAT KIDNEY N SUP SP L GKSLHospitals & Diagnostic Centres | +212.6% | 18.9% | 54.7x Fair | -9% vs avg | +27.4% |
KRSNAA DIAGNOSTICS LTD KRSNAAHospitals & Diagnostic Centres | +3.5% | 12.7% | 18.0x Undervalued | -70% vs avg | -28.0% |
GPT HEALTHCARE LIMITED GPTHEALTHHospitals & Diagnostic Centres | +17.8% | 9.6% | 26.9x Undervalued | -55% vs avg | -0.2% |
ASTER DM QUALITY CARE LTD ASTERDMHospitals & Diagnostic Centres | +21.6% | 6.5% | 138.3x Premium | +130% vs avg | +39.5% |
NARAYANA HRUDAYALAYA LTD. NHHospitals & Diagnostic Centres | +80.4% | 9.0% | 45.2x Undervalued | -25% vs avg | +1.0% |
GLOBAL HEALTH LIMITED MEDANTAHospitals & Diagnostic Centres | +26.5% | 11.9% | 68.4x Fair | +14% vs avg | +6.3% |
FORTIS HEALTHCARE LTD FORTISHospitals & Diagnostic Centres | +17.5% | 11.0% | 65.4x Fair | +9% vs avg | -3.4% |
APOLLO HOSPITALS ENTER. L APOLLOHOSPHospitals & Diagnostic Centres | +18.1% | 7.7% | 64.9x Fair | +8% vs avg | +12.1% |
Comparable-scale peer data is limited — showing nearest stored business/industry peers instead of an empty comparison.
Financials
Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.
Latest revenue
₹14 CrMar 2026Latest net profit
₹-0.32 CrMar 2026Latest EPS
₹-0.15Mar 2026Net margin
3.5%Mar 2026Performance
Bars show revenue and net profit. The line shows net margin.
- Revenue
- Net income
- Net margin %
Earnings
Revenue is shown in crores. EPS is rupees per share.
- Revenue
- EPS
Revenue to profit conversion
Bridge from operating numbers to profit for the latest reported period.
Latest reported period: Mar 2026
Debt level and coverage
Debt, cash and free cash flow compared on the same crore scale.
- Debt
- Free cash flow
- Cash & equivalents
Results
| Metric | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 11.17 | 12.57 | 12.73 | 12.03 | 10.88 | 12.89 | 12.91 | 12.25 | 11.51 | 13.52 | 13.04 | 13.55 | 13.61 |
| Expenses + | 9.78 | 10.18 | 10.92 | 10.45 | 10.12 | 11.23 | 11.76 | 11.46 | 11.68 | 12.04 | 12.27 | 12.89 | 13.13 |
| Operating Profit | 1.39 | 2.39 | 1.81 | 1.58 | 0.76 | 1.66 | 1.15 | 0.79 | -0.17 | 1.48 | 0.77 | 0.66 | 0.48 |
| OPM % | 12.44% | 19.01% | 14.22% | 13.13% | 6.99% | 12.88% | 8.91% | 6.45% | -1.48% | 10.95% | 5.90% | 4.87% | 3.53% |
| Other Income + | 0.36 | 0.29 | 0.28 | 0.34 | 0.40 | 0.31 | 0.27 | 0.22 | 0.52 | 0.19 | 0.27 | 0.24 | 0.47 |
| Interest | 0.02 | 0.02 | 0.01 | 0.04 | 0.03 | 0.06 | 0.08 | 0.13 | 0.09 | 0.12 | 0.12 | 0.29 | 0.33 |
| Depreciation | 0.78 | 0.73 | 0.89 | 0.98 | 1.12 | 1.06 | 1.23 | 1.31 | -0.58 | 0.82 | 0.85 | 0.98 | 1.10 |
| Profit before tax | 0.95 | 1.93 | 1.19 | 0.90 | 0.01 | 0.85 | 0.11 | -0.43 | 0.84 | 0.73 | 0.07 | -0.37 | -0.48 |
| Tax % | 31.58% | 27.98% | 28.57% | 26.67% | -200.00% | 28.24% | 9.09% | -44.19% | 70.24% | 24.66% | -71.43% | -29.73% | -33.33% |
| Net Profit + | 0.65 | 1.38 | 0.85 | 0.66 | 0.02 | 0.62 | 0.10 | -0.24 | 0.25 | 0.54 | 0.12 | -0.26 | -0.32 |
| EPS in Rs | 0.31 | 0.66 | 0.41 | 0.32 | 0.01 | 0.30 | 0.05 | -0.12 | 0.12 | 0.26 | 0.06 | -0.13 | -0.15 |
| Raw PDF |
All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).
Events Timeline
Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of The Unaudited Financial Results For The Quarter Ended June 30, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018